Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.

Healthcare Brew

Welcome to the World of Tomorrow today! Or, at the very least, welcome to CES 2024 coverage. Healthcare Brew traveled to Las Vegas to explore the cool, the weird, the wild, and the not-yet-ready-for-primetime technology companies are unveiling. 

CES 2024

Maia Anderson

Health tech startups were focused on bringing healthcare home. 

The coolest health tech on display at CES 2024

Cardiovascular diseases cost the US roughly $219 billion annually. 

Wearables could help doctors identify cardiovascular disease earlier 

CES put an emphasis on using digital health to increase access to high-quality healthcare, attendees said.

Healthcare leaders share their biggest takeaways from CES 2024

The small device can take a patient’s heart rate, temperature, and blood oxygen level as well as listen to their lungs. 

BeamO medical device lets patients take their own vitals at home 

The commissioner detailed the goals for the new committee during a session at CES. 

FDA Commissioner Robert Califf on the agency’s new digital health committee 

President and CEO Gail Boudreaux outlined the insurance giant’s strategy during a keynote speech at CES. 

How Elevance Health is using generative AI to try to simplify healthcare

Bossy Show

Brew Markets

CFO Brew

Morning Brew

Double Shot

Tech Brew

Future Social

HR Brew

Incrypto

IT Brew

Marketing Brew

Money Scoop

Money With Katie

Raise

Retail Brew

Sidekick

The Playbook

What healthcare professionals should know about Ozempic

“Our technology can automate a lot of the clerical work that crushes my soul at night as a cardiologist.”

–Shivdev Rao, co-founder of Abridge

How Abridge uses generative AI to reduce clinician burnout

Read about the current state of healthcare employees, the warning signs of compassion fatigue, how to cope with burnout, and how hospital administration can support staff.

Navigating the realities of burnout and compassion fatigue in the healthcare industry

Bench to Bedside & Beyond: The Future of Health Tech

Reducing Friction Through a Modernized Claims Payment Experience

Is New Technology Building a Bridge or Barrier in Access to Healthcare?

Latest

News

Explainers

Analysis

Profiles

Process

Women's health

Staffing

Medicaid

Digital Health

Weight loss

Abortion

Telehealth

Venture Capital

Covid-19

Read stories about the freshest topics in healthcare

Payers

Tech

Startups

Pharma

Hospitals & Facilities

Direct Care

Deep Dives

Register for upcoming events or check out our on-demand library

IRL Events

Webinars

Virtual Events

Subscribe to Healthcare Brew to get healthcare industry news you'll actually want to read

Hospitals and Facilities

Topics

Long-form

State of the Industry: Hospitals

Industry Profiles

Resources

Events

Though Anthem reversed a controversial policy, the fight between the two parties is far from over. 

Caroline Catherman

Morning Brew logo next to a phone showing the Morning Brew Daily newsletter

The chain is reportedly in talks for a deal with private equity firm Sycamore Partners. 

Walgreens’s private equity buyout unlikely, analysts say 

Illustration: Anna Kim, Photos: Adobe Stock

On November 25, Cassava Sciences ended a Phase 3 trial of its controversial Alzheimer’s drug, simufilam, following years of scrutiny.

RIP simufilam, we hardly knew ye 

Elevance President and CEO Gail Boudreaux. Taylor Hill/Getty Images

FDA Commissioner Robert Califf. Drew Angerer/Getty Images

Anesthesiologists say this is just one example of what they view as a larger problem.

Anthem canceled ‘unprecedented’ anesthesia payment plan, but controversy remains